Hot Pursuit     17-May-24
Zydus Lifesciences Ltd spurts 2.36%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1032.8, up 2.36% on the day as on 12:49 IST on the NSE. The stock is up 103.29% in last one year as compared to a 23.95% gain in NIFTY and a 54.96% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 1032.8, up 2.36% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 22472.05. The Sensex is at 73945.43, up 0.38%. Zydus Lifesciences Ltd has added around 10.22% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 2.4% in last one month and is currently quoting at 18996.15, down 0.14% on the day. The volume in the stock stood at 18.21 lakh shares today, compared to the daily average of 15.62 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1038.75, up 2.44% on the day. Zydus Lifesciences Ltd is up 103.29% in last one year as compared to a 23.95% gain in NIFTY and a 54.96% gain in the Nifty Pharma index.

The PE of the stock is 37.76 based on TTM earnings ending December 23.

Previous News
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Lifesciences fixes record date for buyback of shares
 ( Market Beat - Reports 09-Feb-24   17:03 )
  Zydus enters into licensing and supply agreement with MSN Laboaratories
 ( Corporate News - 17-May-24   09:07 )
  Zydus Lifesciences receives USFDA approval for Dapsone Gel 7.5%
 ( Corporate News - 09-May-24   12:36 )
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus Life gets US FDA nod for seizure treatment drug Lacosamide
 ( Hot Pursuit - 16-Dec-23   15:37 )
  Zydus Life receives USFDA approval for Zinc Sulfate Injection
 ( Hot Pursuit - 24-Aug-23   11:50 )
  Zydus Lifesciences Ltd spurts 1.58%
 ( Hot Pursuit - 14-Jun-23   13:05 )
  Board of Zydus Lifesciences approves buyback of Rs 600 cr
 ( Corporate News - 09-Feb-24   17:50 )
  Zydus Life gains on USFDA nod for phase 2 clinical trial of ZYIL1
 ( Hot Pursuit - 18-Dec-23   09:22 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top